calcipotriol 50micrograms/g ointment
sandoz ltd - calcipotriol - cutaneous ointment - 50microgram/1gram
calcipotriol 50micrograms/ml scalp solution
sandoz ltd - calcipotriol monohydrate - cutaneous solution - 50microgram/1ml
sorilux calcipotriene aerosol foam
stiefel laboratories inc - calcipotriene (unii: 143nq3779b) (calcipotriene - unii:143nq3779b) - calcipotriene 50 ug in 1 g
calcipotriene 0.005% / diclofenac sodium 3% / hyaluronic acid sodium salt 2% / niacinamide 2% cream
sincerus florida, llc - calcipotriene (unii: 143nq3779b) (calcipotriene - unii:143nq3779b), diclofenac sodium (unii: qtg126297q) (diclofenac - unii:144o8ql0l1), hyaluronate sodium (unii: yse9ppt4th) (hyaluronic acid - unii:s270n0trqy), niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4) -
calcipotriene 0.005% / clobetasol propionate 0.05% solution
sincerus florida, llc - calcipotriene (unii: 143nq3779b) (calcipotriene - unii:143nq3779b), clobetasol propionate (unii: 779619577m) (clobetasol - unii:adn79d536h) -
calcipotriene 0.005% / clobetasol propionate 0.05% solution
sincerus florida, llc - calcipotriene (unii: 143nq3779b) (calcipotriene - unii:143nq3779b), clobetasol propionate (unii: 779619577m) (clobetasol - unii:adn79d536h) -
calcipotriol/betamethasone sandoz 50/500
sandoz new zealand limited - betamethasone dipropionate 0.643 mg/g equivalent to betamethasone 0.50mg; calcipotriol monohydrate 0.0522 mg/g equivalent to calcipotriol 0.050mg - topical ointment - active: betamethasone dipropionate 0.643 mg/g equivalent to betamethasone 0.50mg calcipotriol monohydrate 0.0522 mg/g equivalent to calcipotriol 0.050mg excipient: d-alpha tocoferol liquid paraffin oleyl alcohol white soft paraffin - calcipotriol and betamethasone ointment is indicated for the once daily topical treatment of plaque-type psoriasis vulgaris amenable to topical therapy in patients 18 years and older.
calcipotriol/betamethasone (teva)
teva pharma (new zealand) limited - betamethasone dipropionate 0.643 mg/g equivalent to betamethasone base 0.500 mg/g; calcipotriol 0.05 mg/g; - topical ointment - active: betamethasone dipropionate 0.643 mg/g equivalent to betamethasone base 0.500 mg/g calcipotriol 0.05 mg/g excipient: butylated hydroxytoluene liquid paraffin polyoxypropylene monostearyl ether white soft paraffin - calcipotriol /betamethasone (teva) is indicated for the once daily topical treatment of plaque-type psoriasis vulgaris amenable to topical therapy in adult patients 18 years and older.
trionex- calcipotriene cream, 0.005% and transparent dressing kit
v2 pharma, llc - calcipotriene (unii: 143nq3779b) (calcipotriene - unii:143nq3779b) - do not use if known hypersensitivity to any of the listed ingredients of any of the components included on the kit. calcipotriene cream, 0.005%, is indicated for the treatment of plaque psoriasis. the safety and effectiveness of topical calcipotriene in dermatoses other than psoriasis have not been established. calcipotriene cream is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation. it should not be used by patients with demonstrated hypercalcemia or evidence of vitamin d toxicity. calcipotriene cream should not be used on the face.
calcipotriene 0.005% / triamcinolone acetonide 0.1% ointment
sincerus florida, llc - calcipotriene (unii: 143nq3779b) (calcipotriene - unii:143nq3779b), triamcinolone acetonide (unii: f446c597ka) (triamcinolone acetonide - unii:f446c597ka) -